NICE recommends Midostaurin for rare blood disorder
Midostaurin can be used to treat advanced systemic mastocytosis in adults, recommended NICE in the draft guidance published on Thursday (August 19).
Following the new...
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc